SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Aoi W, Naito Y, Sakuma K, et al. Astaxanthin limits exercise-induced skeletal and cardiac muscle damage in mice. Antioxid Redox Signal 2003;5:139144.
  • 2
    Astorg P, Gradelet S, Leclerc J, Canivenc MC, Siess MH. Effects of β-carotene and canthaxanthin on liver xenobiotic-metabolizing enzymes in the rat. Food Chem Toxicol 1994;32:735742.
  • 3
    Bertram JS. Carotenoids and gene regulation. Nutr Rev 1999;57:182191.
  • 4
    Beutner S, Bloedorn B, Frixel S, et al. Quantitative assessment of antioxidant properties of natural colorants and phytochemicals: Carotenoids. Avonoids, phenols and indigoids. The role of β-carotene in antioxidant functions. J Sci Food Agric 2001;81:559568.
  • 5
    Bikádi Z, Zsila F, Deli J, Mady G, Simonyi M. The supramolecular structure of self-assembly formed by capsanthin derivatives. Enantiomer 2002;7:6776.
  • 6
    Bodor N, Buchwald P. Drug targeting by retrometabolic design: Soft drugs and chemical delivery systems. J Recept Signal Transduct Res 2001;21:287310.
  • 7
    Bodor N. Retrometabolic drug design-novel aspects, future directions. Pharmazie 2001;56(Suppl 1):S6774.
  • 8
    Bowen PE, Herbst-Espinosa SM, Hussain EA, Stacewicz-Sapuntzakis M. Esterification does not impair lutein bioavailability in humans. J Nutr 2002;132:36683673.
  • 9
    Briguori C, Colombo A, Airoldi F, et al. Statin administration before percutaneous coronary intervention: Impact on periprocedural myocardial infarction. Eur Heart J 2004;25:18221828.
  • 10
    Britton G. Structure and properties of carotenoids in relation to function. FASEB J 1995;9:15511558.
  • 11
    BrittonG, Liaaen-JensenS, PfanderH, MercadanteAZ, EgelandES, eds.: Carotenoids handbook. Basel : Birkhäuser, 2004.
  • 12
    Burton GW, Ingold KU. β-Carotene: An unusual type of lipid antioxidant. Science 1984;224:569573.
  • 13
    Cardounel AJ, Dumitrescu C, Zweier JL, Lockwood SF. Direct superoxide anion scavenging by a disodium disuccinate astaxanthin derivative: Relative efficacy of individual stereoisomers versus the statistical mixture of stereoisomers by electron paramagnetic resonance imaging. Biochem Biophys Res Commun 2003;307:704712.
  • 14
    Coral-Hinostroza GN, Ytrestoyl T, Ruyter B, Bjerkeng B. Plasma appearance of unesterified astaxanthin geometrical E/Z and optical R/S isomers in men given single doses of a mixture of optical 3 and 3′R/S isomers of astaxanthin fatty acyl diesters. Comp Biochem Physiol C Toxicol Pharmacol 2004;139:99110.
  • 15
    Curry S, Brick P, Franks NP. Fatty acid binding to human serum albumin: New insights from crystallographic studies. Biochim Biophys Acta 1999;1441:131140.
  • 16
    Duilio C, Ambrosio G, Kuppusamy P, DiPaula A, Becker LC, Zweier JL. Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia. Am J Physiol Heart Circ Physiol 2001;280:H26492657.
  • 17
    Ernst H. Recent advances in industrial carotenoid synthesis. Pure Appl Chem 2002;74:22132226.
  • 18
    Foss BJ, Naess SN, Sliwka HR, Partali V. Stable and highly water-dispersible, highly unsaturated carotenoid phospholipids-surface properties and aggregate size. Angew Chem Int Ed 2003;42:52375240.
  • 19
    Foss BJ, Sliwka HR, Partali V, Cardounel AJ, Zweier JL, Lockwood SF. Direct superoxide anion scavenging by a highly water-dispersible carotenoid phospholipid evaluated by electron paramagnetic resonance (EPR) spectroscopy. Bioorg Med Chem Lett 2004;14:28072812.
  • 20
    Foss BJ, Sliwka HR, Partali V, et al. Hydrophilic carotenoids: Surface properties and aggregation behavior of a highly unsaturated carotenoid lysophospholipid. Chem Phys Lipids 2005;134:8596.
  • 21
    Frey DA, Kataisto EW, Ekmanis JL, O'Malley S, Lockwood SF. The efficient synthesis of disodium disuccinate astaxanthin (Cardax). Org Process Res Dev 2004;8:796801.
  • 22
    Goto S, Kogure K, Abe K, et al. Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin. Biochim Biophys Acta 2001;1512:251258.
  • 23
    Gradelet S, Astorg P, Leclerc J, Chevalier J, Vernevaut MF, Siess MH. Effects of canthaxanthin, astaxanthin, lycopene and lutein on liver xenobiotic-metabolizing enzymes in the rat. Xenobiotica 1996;26:4963.
  • 24
    Gradelet S, Leclerc J, Siess MH, Astorg PO. β-Apo-8′-carotenal, but not β-carotene, is a strong inducer of liver cytochromes P4501A1 and 1A2 in rat. Xenobiotica 1996;26:909919.
  • 25
    Gross GJ, Lockwood SF. Cardioprotection and myocardial salvage by a disodium disuccinate astaxanthin derivative (CardaxTM). Life Sci 2004;75:215224.
  • 26
    Gross GJ, Lockwood SF. Acute and chronic administration of disodium disuccinate astaxanthin (CardaxTM) produces marked cardioprotection in dog hearts. Mol Cell Biochem 2005;272:221227.
  • 27
    Hix LM, Lockwood SF, Bertram JS. Upregulation of connexin 43 protein expression and increased gap junctional communication by water soluble disodium disuccinate astaxanthin derivatives. Cancer Lett 2004;211:2537.
  • 28
    Hix LM, Lockwood SF, Bertram JS. Bioactive carotenoids: Potent antioxidants and regulators of gene expression. Redox Rep 2004;9:181191.
  • 29
    Hix LM, Vine AL, Lockwood SF, Bertram JS. Retinoids and carotenoids as cancer chemopreventive agents: Role of up regulated gap junctional communication. In: PackerL, Obermueller-JevicU, KraemerK, SiesH, eds. Carotenoids and retinoids: Molecular aspects and health issues. Champaign , IL : AOCS Press, 2005;182203.
  • 30
    Hix LM, Frey DA, Mc Laws MD, Østerlie M, Lockwood SF, Bertram JS. Inhibition of chemically-induced neoplastic transformation by a novel tetrasodium diphosphate astaxanthin derivative. Carcinogenesis 2005; in press.
  • 31
    Iwamoto T, Ho Soda K, Hirano R, et al. Inhibition of low-density lipoprotein oxidation by astaxanthin. J Atheroscler Thromb 2000;7:216222.
  • 32
    Jackson HL, Cardounel AJ, Zweier JL, Lockwood SF. Synthesis, characterization, and direct aqueous superoxide anion scavenging of a highly water-dispersible astaxanthin-amino acid conjugate. Bioorg Med Chem Lett 2004;14:39853991.
  • 33
    Jewell C, O'Brien NM. Effect of dietary supplementation with carotenoids on xenobiotic metabolizing enzymes in the liver, lung, kidney and small intestine of the rat. Br J Nutr 1999;81:235242.
  • 34
    Jyonouchi H, Sun S, Iijima K, Gross MD. Antitumor activity of astaxanthin and its mode of action. Nutr Cancer 2000;36:5965.
  • 35
    Kandzari DE, Labinaz M, Cantor WJ, et al. Reduction of myocardial ischemic injury following coronary intervention (the MC-1 to eliminate necrosis and damage trial). Am J Cardiol 2003;92:660664.
  • 36
    Kistler A, Liechti H, Pichard L, et al. Metabolism and CYP-inducer properties of astaxanthin in man and primary human hepatocytes. Arch Toxicol 2002;75:665675.
  • 37
    Kurihara H, Koda H, Asami S, Kiso Y, Tanaka T. Contribution of the antioxidative property of astaxanthin to its protective effect on the promotion of cancer metastasis in mice treated with restraint stress. Life Sci 2002;70:25092520.
  • 38
    Lauver DA, Lockwood SF, Lucchesi BR. Disodium disuccinate astaxanthin (Cardax) attenuates complement activation and reduces myocardial injury following ischemia/reperfusion. J Pharmacol Exp Ther 2005;314:686692.
  • 39
    Lee C, Miura K, Liu X, Zweier JL. Biphasic regulation of leukocyte superoxide generation by nitric oxide and peroxynitrite. J Biol Chem 2000;275:3896538972.
  • 40
    Lee SJ, Bai SK, Lee KS, et al. Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing IκB kinase-dependent NFκB activation. Mol Cells 2003;16:97105.
  • 41
    Li W, Hellsten A, Jacobsson LS, Blomqvist HM, Olsson AG, Yuan XM. α-Tocopherol and astaxanthin decrease macrophage infiltration, apoptosis and vulnerability in atheroma of hyperlipidaemic rabbits. J Mol Cell Cardiol 2004;37:969978.
  • 42
    Lockwood SF, O'Malley S, Mosher GL. Improved aqueous solubility of crystalline astaxanthin (3,3′-dihydroxy-β,β-carotene-4,4′-dione) by Captisol (sulfobutyl ether β-cyclodextrin). J Pharm Sci 2003;92:922926.
  • 43
    Martin H, Jager C, Ruck C, Schmidt M, Walsh R, Paust J. Anti- and prooxidant properties of carotenoids. J Prakt Chem 1999;341:302308.
  • 44
    Maxwell SR, Lip GY. Reperfusion injury: A review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol 1997;58:95117.
  • 45
    Miki W. Biological functions and activities of animal carotenoids. Pure Appl Chem 1991;63:141146.
  • 46
    Milon A, Wolff G, Ourisson G, Nakatani Y. Organization of carotenoid-phospholipid bilayer systems. Incorporation of zeaxanthin, astaxanthin, and their C50 homologues into dimyristoylphosphatidylcholine vesicles. Helv Chim Acta 1986;69:1224.
  • 47
    Odeberg JM, Lignell A, Pettersson A, Hoglund P. Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations. Eur J Pharm Sci 2003;19:299304.
  • 48
    Ohgami K, Shiratori K, Kotake S, et al. Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Invest Ophthalmol Vis Sci 2003;44:26942701.
  • 49
    Oliveros E, Braun AM, Aminian-Saghafi T, Sliwka HR. Quenching of singlet oxygen by carotenoid derivatives: Kinetic analysis by near-infrared luminescence. New J Chem 1994;18:535539.
  • 50
    Olson JA. Benefits and liabilities of vitamin a and carotenoids. J Nutr 1996;126:1208S1212S.
  • 51
    Olson JA. Bioavailability of carotenoids. Arch Latinoam Nutr 1999;49:21S25S.
  • 52
    Østerlie M, Bjerkeng B, Liaaen-Jensen S. Plasma appearance and distribution of astaxanthin E/Z and R/S isomers in plasma lipoproteins of men after single dose administration of astaxanthin. J Nutr Biochem 2000;11:482490.
  • 53
    Papas AM. Antioxidant status: Diet, health and disease; part I: Factors affecting antioxidant status and its role. Mature Merd 999;November/December:315319.
  • 54
    Parker RS. Absorption, metabolism, and transport of carotenoids. FASEB J 1996;10:542551.
  • 55
    Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation 2004;110:674678.
  • 56
    Shimidzu N, Goto M, Miki W. Carotenoids as singlet oxygen quenchers in marine organisms. Fisheries Sci 1996;62:134137.
  • 57
    Showalter LA, Weinman SA, Osterlie M, Lockwood SF. Plasma appearance and tissue accumulation of non-esterified, free astaxanthin in C57BL/6 mice after oral dosing of a disodium disuccinate diester of astaxanthin (HeptaxTM). Comp Biochem Physiol C Toxicol Pharmacol 2004;137:227236.
  • 58
    Simonyi M, Bikadi Z, Zsila F, Deli J. Supramolecular exciton chirality of carotenoid aggregates. Chirality 2003;15:680698.
  • 59
    Spiller GA, Dewell A. Safety of an astaxanthin-rich haematococcus pluvialis algal extract: A randomized clinical trial. J Med Food 2003;6:5156.
  • 60
    Zsila F, Deli J, Bikádi Z, Simonyi M. Supramolecular assemblies of carotenoids. Chirality 2001;13:739744.
  • 61
    Zsila F, Simonyi M, Lockwood SF. Interaction of the disodium disuccinate derivative of meso-astaxanthin with human serum albumin: From chiral complexation to self-assembly. Bioorg Med Chem Lett 2003;13:40934100.
  • 62
    Zsila F, Fitos I, Bikadi Z, Simonyi M, Jackson HL, Lockwood SF. In vitro plasma protein binding and aqueous aggregation behavior of astaxanthin dilysinate tetrahydrochloride. Bioorg Med Chem Lett 2004;14:53575366.
  • 63
    Zsila F, Molnár P, Deli J, Lockwood S. Circular dichroism and absorption spectroscopic data reveal binding of the natural cis-carotenoid bixin to human α1-acid glycoprotein. Bioorg Chem 2005;33:298309.